We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Particle Sciences, a Lubrizol LifeSciences company and US-based pharmaceutical CDMO, is opening a new commercial drug product manufacturing facility at the end of Q4 2018.